Race says bisantrene highly active in a mouse model of multiple myeloma
Race Oncology (ASX:RAC) has reported the results of preclinical work performed under contract by US-based Labcorp of a mouse model involving bisantrene in combination with carfilzomib. Race said the combination was effective against human multiple myeloma. …